News by Year - 2019

CCGHE at the 2019 Union TB Conference

Post Date: 
2019 Union World Conference on Lung Health
CCGHE researchers and faculty will be in Hyderbad for the Union Conference--check out our agenda!

Tuberculosis Prevention Therapy in HIV+ Pregnant Women versus Waiting until After Delivery: A Delicate Risk-Benefit Conversation

Post Date: 
CCGH Globe
Study findings suggest that waiting until after delivery to start preventive therapy is associated with fewer adverse events

Integrated Mobile Health Applications Show Promise for Quicker Care of Drug-Resistant TB in South Africa

Post Date: 
Jane McKenzie-White
Researchers at Johns Hopkins and other institutions developed and tested a suite of mobile health applications that shows great promise for patient care and public health.

In pregnant women on ART, safer to initiate isoniazid after delivery

Post Date: 
Initiating 28-week isoniazid therapy during pregnancy was noninferior to initiating it 12 weeks after delivery to prevent tuberculosis in pregnant women with HIV who are on ART.

In Women with HIV, TB Preventive Therapy Poses Greater Risk in Pregnancy than Postpartum

Post Date: 
NIH Press Release: NIH announces NEJM published findings from the TB APPRISE trial, led by Dr. Amita Gupta

Amita Gupta Named to NIAID Council

Post Date: 
Amita Gupta
CCGHE Deptuy Director Amita Gupta was recently appointed for a 4-year term to the NIAID Advisory Council at the National Institutes of Health

Pune part of clinical trial to prevent TB in people exposed to multi-drug resistant cases

Post Date: 
The Indian Express
PHOENIX Study Team Members meet with local government health officials in Pune
Indian Express: Drs. Vidya Mave and Nishi Suryavanshi are quoted in this news article about a recent PHOENIx trial event at BJGMC Clinical Research Site

BJGMC Team Convenes PHOENIx Pre-study Event for Maharashtra Government TB Program Officials

Post Date: 
Meeting participants, Group Photo
Collaboration and coordination with local government TB program officials are critical for ensuring transparency and a shared understanding of the study’s purpose, methods, consent process, logistics, and potential implications for India’s national TB control efforts.

FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB

Post Date: 
Amita Gupta
Medscape: Dr. Amita Gupta weighs in on the FDA approval of a new drug for XDR-TB

2018 Year in Review

Post Date: 
2018 Year in Review
Our newly released 2018 Annual Report features ongoing and new work underway last year. And boy, what a year it was!

NIH Launches Large TB Prevention Trial for People Exposed to Multidrug-Resistant TB

Post Date: 
Tuberculosis bacteria
NIH Press Release : NIH announces a large international clinical trial to prevent multidrug-resistant TB in children, adolescents, and adults who live with someone who has MDR-TB. CCGHE's Dr. Amita Gupta is a protocol chair.

Pride in Pune: BJGMC TREAT Asia Team Conducts Health Camp

Post Date: 
TREAT Asia Team Members
Pride in Pune: The BJGMC CRS teamed up with the Udaan Trust to convene a sexual health awareness & screening camp

Cured TB patients run risk of lung disease: Study

Post Date: 
The Telegraph (India)
Dr. Akshay Gupte comments on recent findings that many who've recovered from TB face increased risk of COPD

Shahs’ Donation of Mobile Clinic Brings Healthcare to Patients in India

Post Date: 
Raj and Bharti Shah
Philanthrophy Update: The Mobile Health and Wellness Clinic, a gift from Raj and Bharti Shah, CTIS, and the NB Shah Charitable Trust has been a workhorse for delivering health care in Pune, India, right where it's needed.

Connecting the Dots: Johns Hopkins Visiting Professor of Infectious Diseases Dr. Bruno Andrade

Post Date: 
Dr. Bruno Andrade
Andrade has built an impressive research enterprise in Brazil, and a creative way to sustain it

Venezuela: More Aid is Needed in Humanitarian Crisis

Post Date: 
Summary: Dr. Kathleen Page & colleagues briefed the UN Security Council on critical health crisis in Venezuela

Industry Voices—Innovative tools needed to combat the world’s deadliest infectious disease

Post Date: 
Robert Bollinger
In a FierceHealthcare World TB Day Op-ed, Bob Bollinger discusses what's needed to eliminate TB

TB prevention critical among people with HIV

Post Date: 
Infectious Disease News via Healio
Amita Gupta
Infectious Disease News caught up with Dr. Amita Gupta at CROI 2019 to talk about TB prevention among people living with HIV

Celebration of the Dedicated Participants and Staff of the REPRIEVE Study in Pune, India

Post Date: 
REPRIEVE Team Members of the BJGMC Clinical Research Site
Staff and nearly 140 participants in the REPRIEVE study gathered for a community event in Pune, India